2021
DOI: 10.1212/wnl.0000000000012070
|View full text |Cite
|
Sign up to set email alerts
|

Intra-arterial Melphalan for Neurologic Non-Langerhans Cell Histiocytosis

Abstract: Note 1. The Article Processing Charge was funded by The Frame Family Fund.This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 8 publications
(15 reference statements)
0
1
0
Order By: Relevance
“…Small case reports/series suggest histiocytic disease is sensitive to melphalan and similarly derived drugs . We have reported a small series of patients with neurologic or orbital histiocytosis treated with intra-arterial melphalan …”
Section: Discussionmentioning
confidence: 99%
“…Small case reports/series suggest histiocytic disease is sensitive to melphalan and similarly derived drugs . We have reported a small series of patients with neurologic or orbital histiocytosis treated with intra-arterial melphalan …”
Section: Discussionmentioning
confidence: 99%